These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Reported results 2007-000236-16 A Double-Blind, Randomized, Placebo- and Active Comparator- Controlled, Parallel Group, Multinational Study to Evaluate the Pharmacokinetics and Pharmacodynamics of IPX056 in Subjects with Established... 2008-05-06 due-trials
Reported results 2009-010193-38 A Placebo-Controlled Study to Evaluate the Safety and Efficacy of IPX066 in Subjects with Parkinson's Disease 2010-09-28 due-trials
Listed as ongoing, but also has a completion date and reported results 2009-014688-37 A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson’s Disease 2011-01-19 bad-data
Listed as ongoing, but also has a completion date and reported results 2009-017182-38 An Open Label Extension Study of the Safety and Clinical Utility of IPX066 in Subjects with Parkinson’s Disease. 2011-10-21 bad-data
Listed as ongoing, but also has a completion date and reported results 2009-017238-39 A Study to Compare IPX066 and Carbidopa/Levodopa/Entacapone (CLE) Followed by an Open-Label Safety Study of IPX066 in Advanced Parkinson’s Disease 2012-01-12 bad-data
Ongoing 2018-002233-37 A randomized controlled study to compare the safety and efficacy of IPX203 with immediate-release carbidopa-levodopa in Parkinson's disease patients with motor fluctuations. not-yet-due
Ongoing 2018-002234-21 AN OPEN-LABEL EXTENSION STUDY OF THE SAFETY AND CLINICAL UTILITY OF IPX203 IN PARKINSON’S DISEASE PATIENTS WITH MOTOR FLUCTUATIONS not-yet-due